amodiaquine has been researched along with Idiopathic Parkinson Disease in 1 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, CH | 1 |
| Han, BS | 1 |
| Moon, J | 1 |
| Kim, DJ | 1 |
| Shin, J | 1 |
| Rajan, S | 1 |
| Nguyen, QT | 1 |
| Sohn, M | 1 |
| Kim, WG | 1 |
| Han, M | 1 |
| Jeong, I | 1 |
| Kim, KS | 2 |
| Lee, EH | 1 |
| Tu, Y | 1 |
| Naffin-Olivos, JL | 1 |
| Park, CH | 1 |
| Ringe, D | 1 |
| Yoon, HS | 1 |
| Petsko, GA | 1 |
1 other study available for amodiaquine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease.
Topics: Amodiaquine; Animals; Behavior, Animal; Chloroquine; Disease Models, Animal; Ligands; Neurogenesis; | 2015 |